15-48488445-C-A
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate
The ENST00000316623.10(FBN1):c.3131G>T(p.Cys1044Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 11/18 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C1044S) has been classified as Pathogenic.
Frequency
Consequence
ENST00000316623.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBN1 | NM_000138.5 | c.3131G>T | p.Cys1044Phe | missense_variant | 26/66 | ENST00000316623.10 | NP_000129.3 | |
FBN1 | NM_001406716.1 | c.3131G>T | p.Cys1044Phe | missense_variant | 25/65 | NP_001393645.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBN1 | ENST00000316623.10 | c.3131G>T | p.Cys1044Phe | missense_variant | 26/66 | 1 | NM_000138.5 | ENSP00000325527 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 03, 2017 | A C1044F variant that is likely pathogenic was identified in the FBN1 gene. It has not been published as pathogenicor been reported as benign to our knowledge, It is not observed in large population cohorts (Lek et al., 2016; 1000Genomes Consortium et al., 2015; Exome Variant Server). The C1044F variant is a non-conservative amino acidsubstitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, sizeand/or other properties. Moreover, this substitution occurs at a position that is conserved across species, and in silicoanalysis predicts this variant is probably damaging to the protein structure/function. Furthermore, the C1044F variantaffects a cysteine residue within a calcium-binding EGF-like domain of the FBN1 gene, which may affect disulfidebonding and is predicted to alter the structure and function of the protein. Cysteine substitutions in the calciumbindingEGF-like domains represent the majority of pathogenic missense changes associated with Marfan syndrome(Collod-Beroud et al., 2003). Finally, a different missense change at the same residue (C1044R) has been reported inthe Human Gene Mutation Database, and also classified as likely pathogenic by GeneDx, in association with Marfansyndrome (Stenson et al., 2014), therefore supporting the functional importance of this region of the protein. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at